Literature DB >> 16583637

Intravitreal bevacizumab in a patient with neovascular glaucoma.

Malik Y Kahook1, Joel S Schuman, Robert J Noecker.   

Abstract

The utility of intravitreal bevacizumab injection in a patient with neovascular glaucoma following central retinal vein occlusion is explored. Bevacizumab (1 mg in 0.04 mL) was used after failed intraocular pressure (IOP) control with transscleral cyclophotocoagulation and panretinal photocoagulation. IOP improved within 2 days and the patient experienced marked improvement in comfort. Bevacizumab may be an effective medication for the treatment of neovascular glaucoma.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16583637

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN： 1542-8877


  39 in total

Review 1.  Medical and surgical treatment of neovascular glaucoma.

Authors:  Lisa C Olmos; Richard K Lee
Journal:  Int Ophthalmol Clin       Date:  2011

2.  Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.

Authors:  L C Olmos; M S Sayed; A L Moraczewski; S J Gedde; P J Rosenfeld; W Shi; W J Feuer; R K Lee
Journal:  Eye (Lond)       Date:  2015-12-18       Impact factor: 3.775

3.  Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues.

Authors:  P J Rosenfeld
Journal:  Br J Ophthalmol       Date:  2007-02       Impact factor: 4.638

Review 4.  Some ethical considerations for the "off-label" use of drugs such as Avastin.

Authors:  D Wong; G Kyle
Journal:  Br J Ophthalmol       Date:  2006-10       Impact factor: 4.638

Review 5.  Neovascular glaucoma.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2007-08-08       Impact factor: 21.198

6.  Effects of bevacizumab loaded PEG-PCL-PEG hydrogel intracameral application on intraocular pressure after glaucoma filtration surgery.

Authors:  Qian Han; Yuqi Wang; Xiabin Li; Ribo Peng; Ailing Li; Zhiyong Qian; Ling Yu
Journal:  J Mater Sci Mater Med       Date:  2015-08-19       Impact factor: 3.896

7.  Intravitreal bevacizumab (avastin) as an adjuvant treatment in cases of neovascular glaucoma.

Authors:  Asaad A Ghanem; Amr M El-Kannishy; Ahmed S El-Wehidy; Amira F El-Agamy
Journal:  Middle East Afr J Ophthalmol       Date:  2009-04

8.  Intravitreal bevacizumab: an analysis of the evidence.

Authors:  Derrick P Smit; David Meyer
Journal:  Clin Ophthalmol       Date:  2007-09

Review 9.  The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice.

Authors:  Nazimul Hussain; Yashoda Ghanekar; Inderjeet Kaur
Journal:  Indian J Ophthalmol       Date:  2007 Nov-Dec       Impact factor: 1.848

10.  Intravitreal bevacizumab in the treatment of neovascular glaucoma secondary to central retinal vein occlusion: a case report.

Authors:  Tarek Alasil; Michael E Rauser
Journal:  Cases J       Date:  2009-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.